Bay City Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5

- Investments
-
174
- Portfolio
-
7
- Exits
-
115

Bay City Capital General Information
Company Description
Founded in 1997, Bay City Capital is a venture capital investment firm based in San Rafael, California. The firm seeks to invest in the life sciences industry, with a focus on investing in companies within the bio-pharmaceuticals, drug discovery, medical devices, nutrition, healthcare IT, and medical diagnostics sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.baycitycapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1000 4th Street
- Suite 500
- San Rafael, CA 94901
- United States
Bay City Capital Investments (174)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Oculis Holding | 28-Apr-2021 | Later Stage VC | Drug Discovery | Generating Revenue/Not Profitable | ||
Bridge Medicines | 12-Nov-2020 | Drug Discovery | Generating Revenue | |||
Xilio Therapeutics | 02-Mar-2020 | Drug Discovery | Generating Revenue | |||
Imara | 01-Feb-2020 | Biotechnology | Profitable | |||
NextCure | 13-Nov-2018 | Biotechnology | Generating Revenue/Not Profitable | |||
Gossamer Bio | 20-Jul-2018 | Drug Discovery | Generating Revenue | |||
Twist Bioscience | 02-Apr-2018 | Drug Discovery | Generating Revenue/Not Profitable | |||
Iterum Therapeutics | 16-Feb-2018 | Drug Discovery | Generating Revenue | |||
Xeris Biopharma Holdings | 13-Feb-2018 | Later Stage VC | Drug Discovery | Generating Revenue/Not Profitable | ||
KBP Biosciences | 05-Jan-2018 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 3 |
Bay City Capital Exits (115)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Oculis Holding | 28-Feb-2023 | Reverse Merger | |
Madrigal Pharmaceuticals | 23-Dec-2022 | ||
Cydan | 31-Dec-2021 | ||
Xilio Therapeutics | 22-Oct-2021 | ||
Presidio Pharmaceuticals | 01-Jan-2021 | ||
Galecto | 29-Oct-2020 | ||
Imara | 12-Mar-2020 | ||
Dermira | 20-Feb-2020 | ||
PharmAkea Therapeutics | 31-Dec-2019 | Merger/Acquisition | |
ATXCo | 25-Sep-2019 | Merger/Acquisition |
Bay City Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Bay City Capital Investments by Industry, Year, and Region
Bay City Capital Co-Investors (10)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Earlybird Venture Capital | 1 |
![]() |
![]() |
||
Novartis Venture Fund |
![]() |
![]() |
|||
Tekla Capital Management |
![]() |
![]() |
|||
VI Partners |
![]() |
![]() |
|||
abrdn Healthcare Investors |
![]() |
![]() |
Bay City Capital FAQs
-
What is Bay City Capital?
Founded in 1997, Bay City Capital is a venture capital investment firm based in San Rafael, California.
-
When was Bay City Capital founded?
Bay City Capital was founded in 1997.
-
Where is Bay City Capital headquartered?
Bay City Capital is headquartered in San Rafael, CA.
-
What is Bay City Capital's total asset value?
Bay City Capital has around
in total assets under management. -
How many investments has Bay City Capital made?
Bay City Capital has made 174 investments.
-
What has Bay City Capital invested in?
Bay City Capital has made numerous investments in companies like Oculis Holding, Bridge Medicines, and Xilio Therapeutics within the Drug Discovery industry.
-
What has Bay City Capital invested in recently?
Bay City Capital's latest investment was on 28-Apr-2021 in Oculis Holding, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »